An Innovative Canadian Pharmaceutical Company

Revenue Projected at $150,000,000 by 2025

Sponsored
Message: AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) Commercializes Drugs from other Parts of the World

Share
New Message
Please login to post a reply